Does DURVALUMAB Cause Hepatic failure? 62 Reports in FDA Database

Q: Does DURVALUMAB cause Hepatic failure?

62 reports of Hepatic failure have been filed with the FDA for DURVALUMAB, representing 0.4% of all DURVALUMAB adverse event reports.

Q: How dangerous is Hepatic failure from DURVALUMAB?

Of 62 reports, 41 (66.1%) resulted in death and 28 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Hepatic failure have been filed in association with DURVALUMAB (IMFINZI). This represents 0.4% of all adverse event reports for DURVALUMAB.

Reports of Hepatic failure with DURVALUMAB

0.4%

of all DURVALUMAB reports

Deaths

Hospitalizations

How Dangerous Is Hepatic failure From DURVALUMAB?

Of the 62 reports, 41 (66.1%) resulted in death, 28 (45.2%) required hospitalization, and 18 (29.0%) were considered life-threatening.

Is Hepatic failure Listed in the Official Label?

Yes, Hepatic failure is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.

What Other Side Effects Does DURVALUMAB Cause?

Death (2,817) Malignant neoplasm progression (1,330) Pneumonitis (827) Radiation pneumonitis (786) Pyrexia (573) Diarrhoea (530) Pneumonia (453) Dyspnoea (444) Interstitial lung disease (430) Off label use (395)

What Other Drugs Cause Hepatic failure?

ACETAMINOPHEN (1,392) RIBAVIRIN (888) CYCLOPHOSPHAMIDE (629) METHOTREXATE (598) BEVACIZUMAB (558) SOFOSBUVIR (525) RITUXIMAB (513) VINCRISTINE (468) DOXORUBICIN (462) PREDNISOLONE (425)

Which DURVALUMAB Alternatives Have Lower Hepatic failure Risk?

DURVALUMAB vs DUTASTERIDE DURVALUMAB vs DUTASTERIDE\TAMSULOSIN DURVALUMAB vs DUVELISIB DURVALUMAB vs DYDROGESTERONE DURVALUMAB vs EBASTINE

DURVALUMAB Full Profile All Hepatic failure Reports All Drugs Causing Hepatic failure DURVALUMAB Demographics